These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21257724)

  • 41. The effects of recombinant human TSH on bone turnover in patients after thyroidectomy.
    Karga H; Papaioannou G; Polymeris A; Papamichael K; Karpouza A; Samouilidou E; Papaioannou P
    J Bone Miner Metab; 2010; 28(1):35-41. PubMed ID: 19548061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term hypothyroidism in thyroid cancer patients and cognitive-motor performance relevant for driving.
    Lodemann E; Bockisch A; Görges R
    Psychoneuroendocrinology; 2012 Oct; 37(10):1726-35. PubMed ID: 22541716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship of serum thyrotropin (TSH) to the thyroid hormones after oral TSH-releasing hormone in patients with preclinical hypothyroidism.
    Staub JJ; Noelpp B; Gräni R; Gemsenjäger E; Hauenstein M; Girard J
    J Clin Endocrinol Metab; 1983 Mar; 56(3):449-53. PubMed ID: 6401757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease.
    Müller B; Tsakiris DA; Roth CB; Guglielmetti M; Staub JJ; Marbet GA
    Eur J Clin Invest; 2001 Feb; 31(2):131-7. PubMed ID: 11168451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in Thyroid Hormone Levels Within the Normal and/or Subclinical Hyper- or Hypothyroid Range Do Not Affect Circulating Irisin Levels in Humans.
    Panagiotou G; Pazaitou-Panayiotou K; Paschou SA; Komninou D; Kalogeris N; Vryonidou A; Mantzoros CS
    Thyroid; 2016 Aug; 26(8):1039-45. PubMed ID: 27267080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
    Turecek PL; Gritsch H; Richter G; Auer W; Pichler L; Schwarz HP
    Thromb Haemost; 1997 Mar; 77(3):591-9. PubMed ID: 9066015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Free thyroid hormones in evaluating persistently elevated thyrotropin levels in children with congenital hypothyroidism on replacement therapy.
    Focarile F; Rondanini GF; Bollati A; Bartolucci A; Chiumello G
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1211-4. PubMed ID: 6490797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.
    Luster M; Handkiewicz-Junak D; Grossi A; Zacharin M; Taïeb D; Cruz O; Hitzel A; Casas JA; Mäder U; Dottorini ME;
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3948-53. PubMed ID: 19773393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
    Pacini F; Molinaro E; Lippi F; Castagna MG; Agate L; Ceccarelli C; Taddei D; Elisei R; Capezzone M; Pinchera A
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating leptin levels are not influenced by thyroid status in hypothyroid and euthyroid women.
    Owecki M; El Ali Z; Wasko R; Nikisch E; Dziubandowska A; Sulikowska A; Sowiński J
    Neuro Endocrinol Lett; 2007 Aug; 28(4):417-21. PubMed ID: 17693966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
    Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
    Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of brown adipose tissue in hypothyroidism.
    Lapa C; Maya Y; Wagner M; Arias-Loza P; Werner RA; Herrmann K; Higuchi T
    Ann Med; 2015; 47(7):538-45. PubMed ID: 26513396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of thyroid function on the coagulation system and its clinical consequences.
    Elbers LPB; Fliers E; Cannegieter SC
    J Thromb Haemost; 2018 Apr; 16(4):634-645. PubMed ID: 29573126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.